Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108026007A reveals Mo-doped Raney Ni catalyst for high-purity diol synthesis. Enables cost reduction in synthetic flavors manufacturing with safer moderate conditions.
Patent CN1144779C details a high-yield 6-step route for FTY-720 precursors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113292517A reveals a mild anion exchange resin method for shikimic acid epoxide synthesis, offering 98-100% yield and enhanced supply chain safety.
Discover the novel CN103880791A method for synthesizing Elliott alcohol. A scalable, high-yield route for resmethrin intermediates offering significant cost reduction.
Novel two-step catalytic method for high-purity 1-tert-butyl-L-glutamic acid. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN100379733C reveals a high-yield synthesis for triazole antifungal intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN102260298B details a high-yield synthesis of key capecitabine intermediates using inosine, offering significant cost reduction and supply chain reliability for manufacturers.
Patent CN106986846B details a safe formic acid method for methylfuran. Reduces costs and improves supply chain reliability for fine chemical intermediates.
Patent CN113773214A reveals a scalable four-step route for N-methyl-D-threonine, eliminating chromatography for significant cost reduction in pharmaceutical manufacturing.
Patent CN101007816A details a chromatography-free route for Biapenem, offering significant cost and scalability advantages for pharmaceutical manufacturers.
Patent CN110483388A reveals high-yield synthesis for nicotinic acid derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel HT-Fen ester synthesis patent CN105753702B offers multi-target metabolic benefits. Scalable route ensures supply continuity for pharma partners.
Discover the advanced synthesis of Entecavir via Patent CN100379736C. A cost-effective, scalable route eliminating toxic reagents for high-purity antiviral API manufacturing.
Novel two-step synthesis of (5-fluoropyrimidin-4-yl) methanol via oxidation and dechlorination. Offers streamlined manufacturing and cost reduction for API intermediates.
Advanced solid-phase synthesis and selective hydrogenolysis process for Buserelin and Goserelin. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Patent CN102532140B reveals advanced meropenem trihydrate synthesis offering improved yield and simplified processing for reliable pharmaceutical intermediates supply chain optimization.
Novel furfural-based route offers high selectivity and mild conditions for 5-AP production ensuring cost reduction in pharma intermediate manufacturing and supply stability.
Novel catalytic hydrogenolysis route improves yield and purity of 2-hydrazinopyridine derivatives, offering cost-effective supply chain solutions.
Advanced preparation of Silodosin intermediate via novel Friedel-Crafts route. Offers high optical purity, reduced toxicity, and scalable manufacturing for global supply chains.
Patent CN108358760A reveals a safer metal hydride palladium system for debenzylation. This breakthrough offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.